Veradigm | MDRX - Ordinary Share Capital


Veradigm reported $106.07M in Ordinary Share Capital for its fiscal quarter ending in December of 2022.





Ordinary Share Capital Change Date
Alcidion AUD 1.34B 0 Dec/2025
Ambu A/S DKK 266.39M 165.6K Mar/2026
Amplifon EUR 265.25M 45.3M Jun/2026
Cardinal Health USD 235M 1000K Mar/2026
Centene USD 493.99M 216K Jun/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Cigna USD 264.6M 1.14M Mar/2026
Coloplast 225.37M 0 Dec/2025
Convatec Group USD 251.5M 0 Dec/2024
CVS Health USD 1.27B 2M Mar/2026
Elevance Health USD 216.84M 528K Jun/2026
General Electric Aerospace USD 1.04B 5.77M Jun/2026
Gulf Medical Proj AED 698.92M 0 Dec/2025
Humana USD 120.08M 18K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Laboratory Of America USD 80.9M 1.4M Jun/2026
Maximus USD 53.11M 563.2M Mar/2026
McKesson USD 280M 156M Dec/2025
Med Life RON 530.82M 0 Dec/2025
Molina Healthcare USD 52M 0 Jun/2026
Omnicell USD 45.48M 2K Jun/2026
Oriola-kd EUR 185.24M 0 Mar/2026
Owens Minor USD 76.39M 911K Dec/2025
Quest Diagnostics USD 110M 1000K Jun/2026
Rede D'or Sao Luiz BRL 2.2B 7.2M Mar/2026
Siemens Healthineers EUR 1.12B 2.36M Mar/2026
Sonova Holding CHF 59.61M 10.56K Jun/2025
Supermax Corporation Bhd MYR 3.06B 0 Mar/2026
UnitedHealth USD 908.14M 468K Jun/2026
Veeva Systems USD 163.2M 1.18M Mar/2026
Veradigm USD 106.07M 103.28M Dec/2022
Xerox USD 126M 2M Mar/2025